Breast cancer is a heterogeneous group of diseases, which is broadly classified in the clinic into three major subtypes based on the expression or absence of estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene PGR and breast carcinoma.